<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of kidney transplant recipients with recurrent FSGS</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of kidney transplant recipients with recurrent FSGS</h1>
<div class="graphic"><div class="figure"><div class="ttl">Treatment of kidney transplant recipients with recurrent FSGS</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">FSGS: focal segmental glomerulosclerosis.<br/>* Recurrent FSGS is the development of primary FSGS in the transplanted kidney in patients with primary FSGS as the cause of end-stage kidney disease in the native kidneys.<br/>¶ Among patients with recurrent FSGS who present with a later onset (ie, &gt;3 months) after transplantation, differentiation between recurrent primary FSGS and de novo secondary FSGS may be challenging. It is particularly important to distinguish true recurrent primary FSGS from secondary causes of FSGS, which are unlikely to respond to therapies used to treat recurrent primary FSGS.<br/>Δ In patients with an identifiable cause of secondary FSGS, initial therapy should be directed against the underlying cause since resolution of the FSGS usually occurs after addressing the underlying cause. As examples, patients with evidence of a viral infection that may cause FSGS should be treated for the viral infection, if possible. Patients who are taking a medication that is known to be associated with FSGS should discontinue this agent to see if proteinuria responds.<br/>◊ A partial remission is defined as a reduction in proteinuria ≥50% to a level between 0.3 and 3.5 g/day.</div><div id="graphicVersion">Graphic 131825 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
